Log in

NYSE:WAT - Waters Stock Price, Forecast & News

$239.60
+1.99 (+0.84 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
$236.22
Now: $239.60
$239.99
50-Day Range
$221.36
MA: $230.56
$239.60
52-Week Range
$199.11
Now: $239.60
$255.21
Volume472,952 shs
Average Volume394,065 shs
Market Capitalization$15.44 billion
P/E Ratio29.51
Dividend YieldN/A
Beta1.04
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. Read More…

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
CUSIP94184810
Phone508-478-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.42 billion
Cash Flow$10.01 per share
Book Value$20.69 per share

Profitability

Net Income$593.79 million

Miscellaneous

Employees7,200
Market Cap$15.44 billion
Next Earnings Date2/4/2020 (Confirmed)
OptionableOptionable

Receive WAT News and Ratings via Email

Sign-up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter.


(Ad)


A devastating technical glitch could crush the next generation of wireless technology before it even launches. With trillions of dollars and millions of jobs at stake, one company with the "5G fix" could put as much as $234,770 in your pocket this year. But Wall Street vultures are circling... you'll need to move quickly or risk missing this $5 bargain.

Waters (NYSE:WAT) Frequently Asked Questions

What is Waters' stock symbol?

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

How will Waters' stock buyback program work?

Waters declared that its Board of Directors has authorized a stock repurchase plan on Tuesday, April 24th 2018, which permits the company to repurchase $3,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 18.2% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's management believes its stock is undervalued.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) posted its quarterly earnings data on Tuesday, October, 29th. The medical instruments supplier reported $2.13 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.13. The medical instruments supplier had revenue of $577.28 million for the quarter, compared to the consensus estimate of $588.35 million. Waters had a return on equity of 77.73% and a net margin of 23.98%. The firm's revenue for the quarter was down .1% on a year-over-year basis. During the same period last year, the business earned $1.92 EPS. View Waters' Earnings History.

When is Waters' next earnings date?

Waters is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Waters.

How can I listen to Waters' earnings call?

Waters will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Waters issued on next quarter's earnings?

Waters updated its fourth quarter earnings guidance on Tuesday, October, 29th. The company provided EPS guidance of $2.95-3.05 for the period, compared to the Thomson Reuters consensus estimate of $3.23. The company issued revenue guidance of $715-729 million, compared to the consensus revenue estimate of $735.22 million.

What price target have analysts set for WAT?

11 brokers have issued 12-month price objectives for Waters' stock. Their forecasts range from $177.00 to $260.00. On average, they expect Waters' share price to reach $210.75 in the next twelve months. This suggests that the stock has a possible downside of 12.0%. View Analyst Price Targets for Waters.

What is the consensus analysts' recommendation for Waters?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 6 sell ratings and 5 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Waters.

Has Waters been receiving favorable news coverage?

Media coverage about WAT stock has been trending somewhat negative this week, InfoTrie reports. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Waters earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned media stories about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Waters.

Are investors shorting Waters?

Waters saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 5,780,000 shares, an increase of 5.7% from the December 15th total of 5,470,000 shares. Based on an average daily volume of 458,500 shares, the short-interest ratio is currently 12.6 days. Currently, 9.0% of the company's stock are short sold. View Waters' Current Options Chain.

Who are some of Waters' key competitors?

What other stocks do shareholders of Waters own?

Who are Waters' key executives?

Waters' management team includes the folowing people:
  • Christopher James O'Connell, Chairman & CEO (Age 52)
  • Mr. Christopher James O'Connell, Chairman & CEO (Age 52)
  • Ms. Sherry L. Buck, Sr. VP & CFO (Age 55)
  • Mr. Francis S. Kim, Sr. VP of Global Operations (Age 52)
  • Mr. Robert G. Carson, Sr. VP of Corp. Devel. & Interim Pres of TA Bus. (Age 45)

Who are Waters' major shareholders?

Waters' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Boston Trust Walden Corp (0.45%), Fenimore Asset Management Inc. (0.18%), Independent Investors Inc. (0.07%), Copper Rock Capital Partners LLC (0.07%), American Research & Management Co. (0.06%) and Nisa Investment Advisors LLC (0.05%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Edward Conard, Elizabeth B Rae, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Institutional Ownership Trends for Waters.

Which major investors are selling Waters stock?

WAT stock was sold by a variety of institutional investors in the last quarter, including Fenimore Asset Management Inc., Assenagon Asset Management S.A., Copper Rock Capital Partners LLC, Nisa Investment Advisors LLC, Boston Trust Walden Corp, State of Alaska Department of Revenue, American Research & Management Co. and Northstar Asset Management LLC. Company insiders that have sold Waters company stock in the last year include Edward Conard, Elizabeth B Rae, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Insider Buying and Selling for Waters.

Which major investors are buying Waters stock?

WAT stock was acquired by a variety of institutional investors in the last quarter, including Meag Munich Ergo Kapitalanlagegesellschaft MBH, Douglass Winthrop Advisors LLC, Diversified Trust Co and IFP Advisors Inc. View Insider Buying and Selling for Waters.

How do I buy shares of Waters?

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Waters' stock price today?

One share of WAT stock can currently be purchased for approximately $239.60.

How big of a company is Waters?

Waters has a market capitalization of $15.44 billion and generates $2.42 billion in revenue each year. The medical instruments supplier earns $593.79 million in net income (profit) each year or $8.29 on an earnings per share basis. Waters employs 7,200 workers across the globe.View Additional Information About Waters.

What is Waters' official website?

The official website for Waters is http://www.waters.com/.

How can I contact Waters?

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]


MarketBeat Community Rating for Waters (NYSE WAT)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  396 (Vote Outperform)
Underperform Votes:  545 (Vote Underperform)
Total Votes:  941
MarketBeat's community ratings are surveys of what our community members think about Waters and other stocks. Vote "Outperform" if you believe WAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WAT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/18/2020 by MarketBeat.com Staff

Featured Article: Penny Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel